Gyno-Pevaryl

Gyno-Pevaryl is a vaginal antifungal product that contains the imidazole agent econazole nitrate as its active ingredient. Marketed in the European Union, the formulation is designed for intravaginal administration, although specific strength details are not publicly disclosed. Econazole nitrate belongs to the D01AC02 ATC class and works by inhibiting fungal ergosterol synthesis. The product is intended for the treatment of vaginal yeast infections common conditions.

Gyno-Pevaryl is indicated for the topical treatment of vaginal candidiasis caused by susceptible Candida species.

- Treatment of acute vaginal yeast infection confirmed by laboratory testing. - Management of recurrent vulvovaginal candidiasis when prescribed by a healthcare professional. - Adjunct therapy for mixed infections where a fungal component is identified. - Use in patients who prefer a localized vaginal formulation over systemic antifungal agents. - Prophylactic application in women undergoing antibiotic therapy that predisposes to yeast overgrowth, as advised by a clinician. - Symptomatic relief of itching, burning, and discharge associated with Candida infection when used according to prescribed regimen.

The safety profile of Gyno-Pevaryl reflects the typical adverse events observed with intravaginal imidazole antifungals.

Common: - Mild vaginal irritation or burning sensation at the site of application. - Localized itching or dryness. - Unpleasant odor or discharge unrelated to infection. - Transient spotting or light bleeding following application. - Increased vaginal discharge that is thin and non‑purulent. - Mild discomfort during intercourse while the medication is present.

Serious: - Severe allergic reaction such as rash, swelling, or difficulty breathing. - Persistent or worsening vaginal symptoms despite therapy. - Signs of secondary bacterial infection, including fever or foul-smelling discharge. - Development of severe pelvic pain or abdominal cramps. - Systemic symptoms such as headache, dizziness, or nausea that persist. - Any reaction requiring immediate medical attention.

Before using Gyno-Pevaryl, certain precautions should be considered to ensure safe and effective treatment.

- Confirm diagnosis of vaginal candidiasis through appropriate clinical evaluation before initiating therapy. - Avoid using the product if you have a known hypersensitivity to econazole nitrate or any imidazole antifungal. - Do not insert the applicator beyond the recommended depth; follow the provided instructions carefully. - Refrain from sexual intercourse, tampon use, or douching for at least 24 hours after application. - If symptoms persist beyond the recommended treatment period, consult a healthcare professional. - Pregnant or breastfeeding women should discuss potential risks with their provider before use.

Gyno-Pevaryl may interact with other substances applied vaginally or systemically; awareness of potential interactions helps maintain therapeutic effectiveness.

Avoid: - Concurrent use of other intravaginal antifungal or antiseptic products, which may reduce efficacy or increase irritation. - Application of vaginal spermicides or lubricants containing non‑oil‑based formulations during treatment.

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of hepatic enzyme inhibition. - Hormonal contraceptives administered vaginally, such as rings, should be monitored for possible reduced absorption. - Use in patients with severe liver disease; although absorption is minimal, caution is advised.